New treatments in psoriasis.
作者信息
Carrascosa Jose-Manuel
机构信息
Servei de Dermatologia, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, España.
出版信息
Med Clin (Barc). 2017 Aug 22;149(4):157-159. doi: 10.1016/j.medcli.2017.03.026. Epub 2017 May 3.
PMID:28476451
Abstract
摘要
相似文献
1
New treatments in psoriasis.银屑病的新疗法。
Med Clin (Barc). 2017 Aug 22;149(4):157-159. doi: 10.1016/j.medcli.2017.03.026. Epub 2017 May 3.
2
Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis.生物制剂治疗重度银屑病与冠状动脉疾病进展变化的相关性研究。
JAMA Dermatol. 2016 Oct 1;152(10):1114-1121. doi: 10.1001/jamadermatol.2016.1984.
3
Risk of malignancy in psoriatic patients: Our clinical experience.银屑病患者的恶性肿瘤风险：我们的临床经验。
Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12476. Epub 2017 Feb 17.
4
Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development.银屑病系统性药物III期试验的纳入和排除标准：药物研发的外部有效性
Br J Dermatol. 2016 Sep;175(3):636-8. doi: 10.1111/bjd.14622. Epub 2016 Jul 5.
5
The role of biologics and other systemic agents in the treatment of pediatric psoriasis.生物制剂和其他全身用药在儿童银屑病治疗中的作用。
Semin Cutan Med Surg. 2010 Mar;29(1):20-7. doi: 10.1016/j.sder.2010.01.003.
6
The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.银屑病治疗中的“转换者”患者概况：从传统药物治疗转换为生物制剂治疗，再从生物制剂治疗转换为传统全身用药治疗。
Br J Dermatol. 2015 Jul;173(1):256-8. doi: 10.1111/bjd.13560. Epub 2015 May 24.
7
Switching biological agents for psoriasis in secondary care: a single-centre, retrospective, open-label study.二级医疗中银屑病生物制剂的转换：一项单中心、回顾性、开放标签研究。
Br J Dermatol. 2014 Apr;170(4):989-90. doi: 10.1111/bjd.12764.
8
[Ambulatory treatment of psoriasis with psoil].[使用psoil对银屑病进行门诊治疗]
Asthet Med (Berl). 1967 Sep 20;16(9):275-80.
9
[Psoriasis].
Ann Dermatol Venereol. 1997;124(1):91-101.
10
Safety of conventional systemic agents and biologic agents in the treatment of psoriasis.治疗银屑病的传统系统药物和生物制剂的安全性。
J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S67-76. doi: 10.2310/7750.2009.00023.
Zotero 插件